David S. Goldfarb
Clinical Chief, Nephrology @NYU Langone Health
Signup · Get unlimited contacts
WORK HISTORY
Clinical Chief, Nephrology @NYU Langone Health
New York, NY, US
EDUCATION
Yale School of Medicine
MD, Medicine
Yale University
BA, Biology
SKILLS
ABOUT DAVID S. GOLDFARB
After a difficult personal experience with a kidney stone that required shock wave treatment, I resolved to take care of my fellow patients. I knew the condition was interesting and often neglected, and I felt I needed to do something about it. My background in physiology meant that I was well prepared to study kidney stones.At NYU Langone, I am committed to patient care and research about kidney stones. I taught kidney physiology at NYU School of Medicine from 2005 til 2022, where I am a professor of medicine and physiology. I also see patients who have calcium stones, uric acid stones, struvite stones, cystinuria, and other genetic causes of kidney stones. I am the chief of nephrology and medical director of hemodialysis at the New York campus of the New York Harbor VA Healthcare System.I’m honored to have held several positions of leadership in the field of nephrology. I was the associate editor of the Clinical Journal of the American Society of Nephrology (CJASN) for five years, and am a past president of the Research on Calculus Kinetics Society (the R.O.C.K. Society) and the New York Society of Nephrology. I also served as vice chair of the American Urological Association’s guideline panel on the medical management of kidney stones, representing the American Society of Nephrology.I currently serve on the medical advisory board of the National Kidney Foundation serving Greater New York, the scientific advisory board of the Oxalosis and Hyperoxaluria Foundation, and board of directors of the International Cystinuria Foundation. Currently I am on the editorial boards of JASN, CJASN, Kidney International, Urolithiasis and Current Opinion in Nephrology and Hypertension. Our goal to \"democratize kidney stone prevention\" was realized by our patent for a high citrate beverage. The patent, held by NYU, Harvard and UCSF was licensed to Moonstone Nutrition, inc. in 2019. Moonstone is a delicious high-citrate beverage based on our patent. see Moonstonenutrition.com and @trymoonstoneI am the principal investigator of the Rare Kidney Stone Consortium’s Cystinuria Project, which was funded by the National Institute of Diabetes and Digestive and Kidney Diseases and the National Center for Advancing Translational Sciences from 20••••19. I’m honored to have been dubbed “Stone Crusher of the Year” by the Oxalosis and Hyperoxaluria Foundation in 2014 and “Nephrologist of the Year” by the American Kidney Fund in 2016.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.